IN BRIEF: Omega Diagnostics Notes Progress Made By UK RT Consortium

Omega Diagnostics Group PLC - sells wide range of specialist products, primarily in the immunoassay, in-vitro diagnostics market - Notes announcement by UK Rapid Test Consortium that Abingdon Health has gained confirmation from the US Food & Drug Administration that Abingdon has completed notification process under the Policy for Coronavirus Disease Tests During the Public Health Emergency.

Abingdon has submitted an Emergency Use Authorization request to the FDA for the AbC-19 rapid test.

Current stock price: 54.00 pence

Year-to-date change: more than tripled from 14.22p

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.